DIMS Institute of Medical Science, Inc.

Developers of Medium-term Carcinogenesis Bioassays in the world. / Contract safety research facility.

Mission

HOME ≫ liver carcinogenesis ≫

Medium-term liver carcinogenesis bioassay

英語版 中期肝発がん性試験

ICH guideline recommends medium-term liver carcinogenesis bioassay as in vivo additional test for carcinogenicity.

Advantage of our medium-term liver carcinogenesis bioassay is to gain useful results in a short time.

It is possible to search for liver carcinogenicity regardless of presence or absence of genotoxicity.

It is useful substitution for a long-term carcinogenicity test, elucidating carcinogenic mechanisms and screening of carcinogenicity.

If a substance is found to be carcinogenic, the strength also can be estimated.

Japanese

Medium-term Carcinogenesis Bioassay/Safety Assessment for Developing Products

DIMS Institute of Medical Science, Inc.

64 Goura, Nishiazai,
Azai-cho, Ichinomiya,
Aichi 491-0113, Japan

Tel: +81-586-51-1201
Fax: +81-586-51-5634

Company Profile

Mobile site

DIMS Institute of Medical Science, Inc.スマホサイトQRコード

Access to the mobile site of DIMS. from this QR code.